Potential Role of Inhibiting the Vascular Endothelial Growth Factor Pathway in Advanced Prostate Cancer
- 1 September 2005
- journal article
- Published by Elsevier BV in Clinical Prostate Cancer
- Vol. 4 (2), 80-82
- https://doi.org/10.1016/s1540-0352(11)70112-3
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Effects of Blocking Platelet-Derived Growth Factor-Receptor Signaling in a Mouse Model of Experimental Prostate Cancer Bone MetastasesJNCI Journal of the National Cancer Institute, 2003
- Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancerThe Prostate, 2000
- Tyrosine Kinases Expressed in Vivo by Human Prostate Cancer Bone Marrow Metastases and Loss of the Type 1 Insulin-Like Growth Factor ReceptorThe American Journal of Pathology, 1999
- Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancerUrology, 1999